glp 1 and ibs is not just a sensitivity issue—it’s an inflammatory condition., For many patients, GLP-1 medications do more than support weight loss. They address one of the root drivers of IBS: inflammation in GLP-1s and IBS: Genetic Insights

L-carnitine via enzyme-catalyzed oxidative kinetic resolution [PMID: 8000862] Laboratory literature summary: L-carnitine via enzyme-catalyzed oxidative kinetic resolution

KLOW at a Glance Who Benefits Most from KLOW In my experience, KLOW is the right call for three distinct groups: The autoimmune / histamine-prone: those with high food intolerances, MCAS, or autoimmune conditions who experience high systemic inflammation

2j), corroborating the data shown in Fig

Research into oral GLP-1 RAs aims to overcome these obstacles by developing small molecule agonists that can provide the same therapeutic benefits without the need for injections